Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SI-BONE, Inc.
Report date February 17, 2026 · Filed February 19, 2026
Section 16 reporting ended · disclosed 2026-02-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 262,376 |
Reported balance
After 2026-02-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-17 · Sale · Disposed 2,091 · Balance 262,376 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $15.15 USD to $15.48 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 259,336 |
Reported balance
After 2026-02-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-02-17 · Sale · Disposed 3,040 · Balance 259,336 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3: This transaction was executed in multiple trades at prices ranging from $15.23 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 257,626 |
Reported balance
After 2026-02-17 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-02-17 · Sale · Disposed 1,710 · Balance 257,626 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4: This transaction was executed in multiple trades at prices ranging from $15.26 USD to $15.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 246,483 |
Reported balance
After 2026-02-17 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-02-17 · Sale · Disposed 11,143 · Balance 246,483 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3: This transaction was executed in multiple trades at prices ranging from $15.23 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 243,418 |
Reported balance
After 2026-02-17 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-02-17 · Sale · Disposed 3,065 · Balance 243,418 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3: This transaction was executed in multiple trades at prices ranging from $15.23 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: Includes 83,423 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $15.15 USD to $15.48 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: This transaction was executed in multiple trades at prices ranging from $15.23 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: This transaction was executed in multiple trades at prices ranging from $15.26 USD to $15.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: Includes 83,423 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2024 Filed Apr 4, 2024 23:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 920 | $15.63 | $14,379.42 |
DisclosureSEC source: 0001562180-24-003312 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 251,533 F4 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $15.39 USD to $15.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Includes 167,475 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 23:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,752 | $15.52 | $27,183.86 |
DisclosureSEC source: 0001562180-24-003312 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,453 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.37 USD to $15.65 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 23:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,555 | $15.49 | $24,088.35 |
DisclosureSEC source: 0001562180-24-003312 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 254,205 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.36 USD to $15.61 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 21:46 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,330 | $16.82 | $56,022.92 |
DisclosureSEC source: 0001562180-24-002691 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,760 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 174,255 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,060 | $20.96 | $64,122.30 |
DisclosureSEC source: 0001562180-24-001537 · primarydocument.xml · nonDerivative · entry 5 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,090 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 174,255 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 313 | $20.96 | $6,558.92 |
DisclosureSEC source: 0001562180-24-001537 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,150 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,502 | $20.96 | $31,474.41 |
DisclosureSEC source: 0001562180-24-001537 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,463 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,123 | $20.96 | $44,487.47 |
DisclosureSEC source: 0001562180-24-001537 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,965 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 824 | $20.96 | $17,266.92 |
DisclosureSEC source: 0001562180-24-001537 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,088 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 17,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000312 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,912 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. F3 · balance_after: Includes 190,406 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 51,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000312 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,910 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2024, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,936 | $20.93 | $40,511.38 |
DisclosureSEC source: 0001562180-24-000268 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,903 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.63 USD to $21.23 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 122,397 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| November 17, 2023 Filed Nov 20, 2023 23:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,996 | $17.78 | $53,274.27 |
DisclosureSEC source: 0001562180-23-007805 · primarydocument.xml · nonDerivative · entry 5 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,839 F6 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F7 · price: The shares were sold in multiple transactions ranging from $17.56 to $17.99 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · balance_after: Includes 125,990 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,076 | $17.69 | $36,733.37 |
DisclosureSEC source: 0001562180-23-007805 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 203,835 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $17.10 USD to $17.88 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,468 | $17.69 | $25,962.46 |
DisclosureSEC source: 0001562180-23-007805 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,911 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,611 | $17.73 | $28,567.38 |
DisclosureSEC source: 0001562180-23-007805 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,379 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.89 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:44 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 306 | $17.38 | $5,318.56 |
DisclosureSEC source: 0001562180-23-007805 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,990 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.605 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:52 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,712 | $21.16 | $36,221.81 |
DisclosureSEC source: 0001562180-23-007213 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,296 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.92 USD to $21.27 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 137,445 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,997 | $21.07 | $63,146.79 |
DisclosureSEC source: 0001562180-23-006437 · primarydocument.xml · nonDerivative · entry 6 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,008 F6 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F7 · price: The shares were sold in multiple transactions ranging from $20.64 to $21.30 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · balance_after: Includes 141,037 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 26 | $21.26 | $552.76 |
DisclosureSEC source: 0001562180-23-006437 · primarydocument.xml · nonDerivative · entry 5 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,005 F6 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,468 | $20.98 | $30,793.21 |
DisclosureSEC source: 0001562180-23-006437 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,031 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $20.80 USD to $21.14 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 306 | $21.05 | $6,439.98 |
DisclosureSEC source: 0001562180-23-006437 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,499 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $21.045 USD to $21.08 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,075 | $20.96 | $43,497.19 |
DisclosureSEC source: 0001562180-23-006437 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,805 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $20.75 USD to $21.13 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 20:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,610 | $21.00 | $33,813.70 |
DisclosureSEC source: 0001562180-23-006437 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,880 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.75 USD to $21.12 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 22:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,712 | $26.68 | $45,684.38 |
DisclosureSEC source: 0001562180-23-005728 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,490 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.58 USD to $26.94 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 152,491 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 22:04 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 48 | $28.59 | $1,372.32 |
DisclosureSEC source: 0001562180-23-005384 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,202 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 156,084 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 17, 2023 Filed May 18, 2023 21:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,997 | $24.91 | $74,643.88 |
DisclosureSEC source: 0001562180-23-004252 · primarydocument.xml · nonDerivative · entry 5 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,250 F5 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F6 · balance_after: Includes 1,891 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023. F7 · balance_after: Includes 156,184 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,468 | $24.82 | $36,432.24 |
DisclosureSEC source: 0001562180-23-004252 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,356 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.22 USD to $24.98 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,610 | $24.80 | $39,923.49 |
DisclosureSEC source: 0001562180-23-004252 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,824 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.22 USD to $24.98 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 306 | $24.67 | $7,550.40 |
DisclosureSEC source: 0001562180-23-004252 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,434 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.23 USD to $24.80 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 18, 2023 21:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,075 | $24.82 | $51,498.39 |
DisclosureSEC source: 0001562180-23-004252 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,740 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.23 USD to $24.98 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,712 | $19.28 | $33,010.10 |
DisclosureSEC source: 0001562180-23-003453 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,815 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.14 to $19.40; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 167,638 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:29 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,081 | $16.46 | $50,706.79 |
DisclosureSEC source: 0001562180-23-001581 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,527 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · balance_after: Includes 171,230 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,458 | $16.80 | $24,494.84 |
DisclosureSEC source: 0001562180-23-001493 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,708 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 171,230 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,009 | $16.60 | $33,357.84 |
DisclosureSEC source: 0001562180-23-001493 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,166 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 302 | $16.77 | $5,065.69 |
DisclosureSEC source: 0001562180-23-001493 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,175 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,424 | $16.71 | $23,797.32 |
DisclosureSEC source: 0001562180-23-001493 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,477 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:29 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 100 | $16.80 | $1,680.03 |
DisclosureSEC source: 0001562180-23-001581 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,608 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 01:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 284 | $16.08 | $4,566.72 |
DisclosureSEC source: 0001562180-23-000497 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,901 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · balance_after: Includes 182,685 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 01:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,000 | $16.01 | $16,010.00 |
DisclosureSEC source: 0001562180-23-000497 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,185 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 01:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 664 | $16.20 | $10,759.52 |
DisclosureSEC source: 0001562180-23-000497 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,185 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:49 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 19,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000312 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,849 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. F3 · balance_after: Includes 183,916 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:49 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 57,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000312 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,690 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2023, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 00:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 307 | $13.07 | $4,012.49 |
DisclosureSEC source: 0001562180-22-007751 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,212 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 107,279 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 00:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,469 | $13.15 | $19,312.36 |
DisclosureSEC source: 0001562180-22-007751 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,519 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 00:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,611 | $13.20 | $21,271.16 |
DisclosureSEC source: 0001562180-22-007751 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,988 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 00:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,077 | $13.23 | $27,480.58 |
DisclosureSEC source: 0001562180-22-007751 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,599 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 01:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 587 | $18.52 | $10,872.30 |
DisclosureSEC source: 0001562180-22-007264 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,676 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 118,733 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 22:33 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,611 | $17.29 | $27,849.68 |
DisclosureSEC source: 0001562180-22-006194 · primarydocument.xml · nonDerivative · entry 4 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,263 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 119,964 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 22:33 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,469 | $17.29 | $25,394.90 |
DisclosureSEC source: 0001562180-22-006194 · primarydocument.xml · nonDerivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · President, Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,874 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.